Lupin's Stock Shows Stabilization Amid Mixed Technical Indicators and Strong Financial Growth
Lupin, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a recent evaluation adjustment reflecting a stabilization in its stock's technical trend. The company showcases strong financial health with a low Debt to Equity ratio and significant growth in operating profit, despite facing challenges in the broader market.
Lupin, a prominent player in the Pharmaceuticals & Biotechnology sector, has recently undergone an evaluation adjustment that reflects changes in its technical indicators. The stock's technical trend has shifted to a sideways movement, indicating a period of stabilization after previous fluctuations. Key metrics reveal a mixed technical landscape: the MACD shows a mildly bullish stance on a weekly basis, while the monthly perspective leans mildly bearish. The Bollinger Bands indicate bullish conditions for both weekly and monthly assessments, suggesting potential upward momentum. However, moving averages present a mildly bearish outlook on a daily basis, highlighting some short-term caution.
In terms of financial health, Lupin has demonstrated a low Debt to Equity ratio of 0.12, which is favorable for long-term stability. The company has also reported impressive growth in operating profit, with an annual increase of 31.55%. Notably, its return on capital employed (ROCE) stands at 19.03%, and net sales have reached a record high of Rs 6,268.34 crore.
Despite a challenging year, where the stock has underperformed relative to the broader market, it has shown resilience with a significant profit increase of 63.4%. The stock is currently trading at a discount compared to its peers, which may present opportunities for investors.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
